Marathon Trading Investment Management LLC Bristol Myers Squibb CO Transaction History

Marathon Trading Investment Management LLC

$358 Million
Q2 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $1.08 Million - $1.29 Million	22,373 New	22,373 $1.15 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $5.35 Million - $7.77 Million	-115,247 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $5.23 Million - $6.82 Million	106,247 Added 1180.52%	115,247 $7.4 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $384,930 - $456,390	9,000 New	9,000 $456,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $2.89 Million - $3.2 Million	-64,827 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $2.92 Million - $3.49 Million	64,827 New	64,827 $3.09 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.93 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.87 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account